Springdale, Ark.-based NowDiagnostics is seeking emergency authorization from the FDA for a COVID-19 antibody blood test, and it is developing two at-home COVID-19 tests that use a patient’s saliva to deliver results in minutes, according to the report.
Walmart has reportedly been in talks with NowDiagnostics for years about selling tests for certain ailments, including the flu, in its stores. Those talks expanded during the COVID-19 pandemic, according to the report.
NowDiagnostics aims to sell each of the three COVID-19 tests for under $10, according to The Wall Street Journal.
Read the full article from The Wall Street Journal here.
More articles on healthcare finance:
32 hospitals have filed for bankruptcy this year
Houston physician sentenced to prison for $17M billing fraud
Chinese billionaire sells $41M worth of CHS stock
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
